Abstract
The ability to differentiate pluripotent stem cells to cardiomyocyte lineages (PSC-CMs) has opened the door to new disease models and innovative drug and cell therapies for the heart. Nevertheless, further advances in the differentiation protocols are needed to fulfill the promise of PSC-CMs. Obstacles that remain include deriving PSC-CMs with proper electromechanical properties, coalescing them into functional tissue structures, and manipulating the genome to test the impact mutations have on arrhythmias and other heart disorders. This chapter gives a brief consideration of these challenges and outlines current methodologies that offer partial solutions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bansilal S, Castellano JM, Fuster V (2015) Global burden of CVD: focus on secondary prevention of cardiovascular disease. Int J Cardiol 201(Suppl 1):S1–S7
Tohyama S et al (2016) Glutamine oxidation is indispensable for survival of human pluripotent stem cells. Cell Metab 23:663–674
Chen VC et al (2015) Development of a scalable suspension culture for cardiac differentiation from human pluripotent stem cells. Stem Cell Res 15:365–375
Pang JKS, Phua QH, Soh BS (2019) Applications of miRNAs in cardiac development, disease progression and regeneration. Stem Cell Res Ther 10:336
Miki K et al (2015) Efficient detection and purification of cell populations using synthetic microRNA switches. Cell Stem Cell 16:699–711
Shiba Y et al (2014) Electrical integration of human embryonic stem cell-derived cardiomyocytes in a guinea pig chronic infarct model. J Cardiovasc Pharmacol Ther 19:368–381
Park M, Yoon YS (2018) Cardiac regeneration with human pluripotent stem cell-derived cardiomyocytes. Korean Circ J 48:974–988
Moldovan NI, Hibino N, Nakayama K (2017) Principles of the Kenzan method for robotic cell spheroid-based three-dimensional bioprinting. Tissue Eng Part B Rev 23:237–244
Masumoto H et al (2016) The myocardial regenerative potential of three-dimensional engineered cardiac tissues composed of multiple human iPS cell-derived cardiovascular cell lineages. Sci Rep 6:29933
Amano Y et al (2016) Development of vascularized iPSC derived 3D-cardiomyocyte tissues by filtration layer-by-layer technique and their application for pharmaceutical assays. Acta Biomater 33:110–121
Takaki T et al (2019) Optical recording of action potentials in human induced pluripotent stem cell-derived cardiac single cells and monolayers generated from long QT syndrome type 1 patients. Stem Cells Int 2019:7532657
Sugiyama A et al (2019) Analysis of electro-mechanical relationship in human iPS cell-derived cardiomyocytes sheets under proarrhythmic condition assessed by simultaneous field potential and motion vector recordings. J Pharmacol Sci 140:317–320
Ruan JL et al (2016) Mechanical stress conditioning and electrical stimulation promote contractility and force maturation of induced pluripotent stem cell-derived human cardiac tissue. Circulation 134:1557–1567
Sasaki D et al (2018) Contractile force measurement of human induced pluripotent stem cell-derived cardiac cell sheet-tissue. PLoS One 13:e0198026
Machiraju P, Greenway SC (2019) Current methods for the maturation of induced pluripotent stem cell-derived cardiomyocytes. World J Stem Cells 11:33–43
Branco MA et al (2019) Transcriptomic analysis of 3D cardiac differentiation of human induced pluripotent stem cells reveals faster cardiomyocyte maturation compared to 2D culture. Sci Rep 9:9229
Nomura S et al (2018) Cardiomyocyte gene programs encoding morphological and functional signatures in cardiac hypertrophy and failure. Nat Commun 9:4435
Kim SI et al (2018) Microhomology-assisted scarless genome editing in human iPSCs. Nat Commun 9:939
Zhang JP et al (2017) Efficient precise knockin with a double cut HDR donor after CRISPR/Cas9-mediated double-stranded DNA cleavage. Genome Biol 18:35
Shiba Y et al (2016) Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts. Nature 538:388–391
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Karagiannis, P., Yoshida, Y. (2021). Making Cardiomyocytes from Pluripotent Stem Cells. In: Yoshida, Y. (eds) Pluripotent Stem-Cell Derived Cardiomyocytes. Methods in Molecular Biology, vol 2320. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-1484-6_1
Download citation
DOI: https://doi.org/10.1007/978-1-0716-1484-6_1
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-1483-9
Online ISBN: 978-1-0716-1484-6
eBook Packages: Springer Protocols